drugset / Trial / NCT03286829
Study to Investigate the Pharmacokinetic Profile
RandomizedParallel-groupSingle-blindOther
Summary
A randomized, open-label, single-dose, parallel-arm, Phase 1 study to investigate the pharmacokinetic profile of a fixed-dose combination tablet of tesofensine and metoprolol (Tesomet) and co-administration of tesofensine plus commercial metoprolol in adult healthy subjects
Timeline
- Start
- 2017-12-18
- Primary completion
- 2018-02-06
- Completion
- 2018-02-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metoprolol | Other / unclassified | 25 mg | — |
| Subject | Metoprolol | Other / unclassified | 100 mg | — |
| Subject | Tesofensine | Small molecule | 0.2 mg | — |
| Subject | Tesofensine | Small molecule | 1 mg | — |
Indications
No indication recorded.